These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism? Vijayakumar V, Ali S, Nishino T, Nusynowitz M. Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385 [Abstract] [Full Text] [Related]
4. A simplified method for treating Graves' disease with radioactive 131I. Masri MT, Menne M, Rooney BL, Caplan RH. Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797 [Abstract] [Full Text] [Related]
5. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease. Sanyal D, Mukhhopadhyay P, Pandit K, Chatterjee J, Raychaudhuri M, Mukherjee S, Chowdhury S. J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646 [Abstract] [Full Text] [Related]
6. Treatment outcome of Graves' disease in Thai children. Somnuke PH, Pusuwan P, Likitmaskul S, Santiprabhob J, Sawathiparnich P. J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924 [Abstract] [Full Text] [Related]
7. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC, Zanin DE, Zweers EJ. Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370 [Abstract] [Full Text] [Related]
9. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Howarth D, Epstein M, Lan L, Tan P, Booker J. Eur J Nucl Med; 2001 Oct 28; 28(10):1489-95. PubMed ID: 11685491 [Abstract] [Full Text] [Related]